Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores

Corticophobia, fear of applying topical corticosteroids (TCSs), is a rising issue in industrialized countries, despite the actual safety of TCSs for atopic dermatitis (AD). Patients attending the Pediatric Dermatology Unit for skin examination were screened for AD. AD patients were included, and dat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical medicine 2023-11, Vol.12 (21), p.6813
Hauptverfasser: Herzum, Astrid, Occella, Corrado, Gariazzo, Lodovica, Pastorino, Carlotta, Viglizzo, Gianmaria
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 21
container_start_page 6813
container_title Journal of clinical medicine
container_volume 12
creator Herzum, Astrid
Occella, Corrado
Gariazzo, Lodovica
Pastorino, Carlotta
Viglizzo, Gianmaria
description Corticophobia, fear of applying topical corticosteroids (TCSs), is a rising issue in industrialized countries, despite the actual safety of TCSs for atopic dermatitis (AD). Patients attending the Pediatric Dermatology Unit for skin examination were screened for AD. AD patients were included, and data were collected. Parental corticophobia was evaluated through the Topical Corticosteroid Phobia (TOPICOP) questionnaire. The χ2 test and logistic regression were used to analyze statistical associations between parental corticophobia (mild/moderate vs. severe) and patients’ and parents’ characteristics. Overall, 100 patients were included (53 females; 47 males; mean age 5.9 years): 44 had mild/moderate AD (EASI ≤ 21), and 56 had severe AD (EASI > 21) (mean EASI 19.7). Of the patients, 33 never consulted healthcare providers for AD, and 67 did. Parental education was low/intermediate in 60 cases and high (gymnasium/university degree) in 40. Mean parental DLQI was 10.7. Mean parental TOPICOP was 39.1%: 51 had mild/moderate corticophobia (TOPICOP ≤ 50%), and 49 had severe corticophobia (TOPICOP > 50%). At the χ2 test, corticophobia was associated with mild/moderate AD (OR 20.9487; 95% CI 7.2489–60.5402; p < 0.001), older age of patients (OR 4.1176; 95% CI 1.7880 to 9.4828; p < 0.001), early disease onset (OR 9.8925; 95% CI 2.7064–36.1596; p < 0.001), and previous healthcare professional consultations (OR 4.9279; 95% CI 1.9335–12.5597; p < 0.001). Also, severe parental corticophobia was very significantly associated with severe parental involvement of life quality (OR 33.3333; 95% CI 10.9046–101.8937; p < 0.001) and with high education of parents (gymnasium or university degree) (29/49) (OR 5.2727; 95% CI 2.1927–12.6790; p < 0.001). At logistic regression, high parental DLQI (p < 0.0001), high parental education (p < 0.0338), older age of patients (p = 0.0015), and early disease onset (p < 0.0513) accounted for major risk factors influencing severe parental corticophobia. Assessing risk factors for corticophobia is essential for addressing groups of parents at higher risk for corticophobia using educational programs, to overcome unfounded fears and augment treatment adherence.
doi_str_mv 10.3390/jcm12216813
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2889995179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A772533471</galeid><sourcerecordid>A772533471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-f77f12d11c84231bf3dc60899553d72bafa92bc71a53f8e1a87757a0277dfba23</originalsourceid><addsrcrecordid>eNptkU1rGzEQhpfSQkOSU_-AIJdAcaIPb0abm9k2TSDBJknPy6xWsuXsrlyNTMklv70yCeSDag6aGZ73ZZgpim-CnyhV8dO1GYSU4kwL9anYkxxgwpVWn9_kX4tDojXPT-upFLBXPNUhJm_CZhVajwyHMC7ZAqMdE7HgWL3yfZcr9tenFZulsPGG_bBxwOSTp3M2I7JEPqtucB0iw7FjN37M2a2nB3aBJoVIzOXGpV-u2P18cVXPF-zOhGjpoPjisCd7-PLvF78vft7Xl5Pr-a-renY9MarSaeIAnJCdECaPrUTrVGfOuK6qslQdyBYdVrI1ILBUTluBGqAE5BKgcy1KtV8cP_tuYviztZSawZOxfY-jDVtqpM5mVSmgyujRB3QdtnHM0-0oLYDrcvpKLbG3jR9dSBHNzrSZAchSqSmITJ38h8rR2SEvfbTO5_47wfdngYmBKFrXbKIfMD42gje7Kzdvrqz-AURMl9U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2888170854</pqid></control><display><type>article</type><title>Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Herzum, Astrid ; Occella, Corrado ; Gariazzo, Lodovica ; Pastorino, Carlotta ; Viglizzo, Gianmaria</creator><creatorcontrib>Herzum, Astrid ; Occella, Corrado ; Gariazzo, Lodovica ; Pastorino, Carlotta ; Viglizzo, Gianmaria</creatorcontrib><description><![CDATA[Corticophobia, fear of applying topical corticosteroids (TCSs), is a rising issue in industrialized countries, despite the actual safety of TCSs for atopic dermatitis (AD). Patients attending the Pediatric Dermatology Unit for skin examination were screened for AD. AD patients were included, and data were collected. Parental corticophobia was evaluated through the Topical Corticosteroid Phobia (TOPICOP) questionnaire. The χ2 test and logistic regression were used to analyze statistical associations between parental corticophobia (mild/moderate vs. severe) and patients’ and parents’ characteristics. Overall, 100 patients were included (53 females; 47 males; mean age 5.9 years): 44 had mild/moderate AD (EASI ≤ 21), and 56 had severe AD (EASI > 21) (mean EASI 19.7). Of the patients, 33 never consulted healthcare providers for AD, and 67 did. Parental education was low/intermediate in 60 cases and high (gymnasium/university degree) in 40. Mean parental DLQI was 10.7. Mean parental TOPICOP was 39.1%: 51 had mild/moderate corticophobia (TOPICOP ≤ 50%), and 49 had severe corticophobia (TOPICOP > 50%). At the χ2 test, corticophobia was associated with mild/moderate AD (OR 20.9487; 95% CI 7.2489–60.5402; p < 0.001), older age of patients (OR 4.1176; 95% CI 1.7880 to 9.4828; p < 0.001), early disease onset (OR 9.8925; 95% CI 2.7064–36.1596; p < 0.001), and previous healthcare professional consultations (OR 4.9279; 95% CI 1.9335–12.5597; p < 0.001). Also, severe parental corticophobia was very significantly associated with severe parental involvement of life quality (OR 33.3333; 95% CI 10.9046–101.8937; p < 0.001) and with high education of parents (gymnasium or university degree) (29/49) (OR 5.2727; 95% CI 2.1927–12.6790; p < 0.001). At logistic regression, high parental DLQI (p < 0.0001), high parental education (p < 0.0338), older age of patients (p = 0.0015), and early disease onset (p < 0.0513) accounted for major risk factors influencing severe parental corticophobia. Assessing risk factors for corticophobia is essential for addressing groups of parents at higher risk for corticophobia using educational programs, to overcome unfounded fears and augment treatment adherence.]]></description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm12216813</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Allergy in children ; Atopic dermatitis ; Atrophy ; Clinical medicine ; Corticosteroids ; Dermatitis ; Dermatology ; Drug therapy ; Eczema ; False information ; Fear &amp; phobias ; Parents ; Parents &amp; parenting ; Pediatrics ; Phobias ; Psychological aspects ; Questionnaires ; Risk factors ; Steroids ; Surveys ; Topical medication</subject><ispartof>Journal of clinical medicine, 2023-11, Vol.12 (21), p.6813</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-f77f12d11c84231bf3dc60899553d72bafa92bc71a53f8e1a87757a0277dfba23</citedby><cites>FETCH-LOGICAL-c398t-f77f12d11c84231bf3dc60899553d72bafa92bc71a53f8e1a87757a0277dfba23</cites><orcidid>0000-0001-6373-8801</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Herzum, Astrid</creatorcontrib><creatorcontrib>Occella, Corrado</creatorcontrib><creatorcontrib>Gariazzo, Lodovica</creatorcontrib><creatorcontrib>Pastorino, Carlotta</creatorcontrib><creatorcontrib>Viglizzo, Gianmaria</creatorcontrib><title>Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores</title><title>Journal of clinical medicine</title><description><![CDATA[Corticophobia, fear of applying topical corticosteroids (TCSs), is a rising issue in industrialized countries, despite the actual safety of TCSs for atopic dermatitis (AD). Patients attending the Pediatric Dermatology Unit for skin examination were screened for AD. AD patients were included, and data were collected. Parental corticophobia was evaluated through the Topical Corticosteroid Phobia (TOPICOP) questionnaire. The χ2 test and logistic regression were used to analyze statistical associations between parental corticophobia (mild/moderate vs. severe) and patients’ and parents’ characteristics. Overall, 100 patients were included (53 females; 47 males; mean age 5.9 years): 44 had mild/moderate AD (EASI ≤ 21), and 56 had severe AD (EASI > 21) (mean EASI 19.7). Of the patients, 33 never consulted healthcare providers for AD, and 67 did. Parental education was low/intermediate in 60 cases and high (gymnasium/university degree) in 40. Mean parental DLQI was 10.7. Mean parental TOPICOP was 39.1%: 51 had mild/moderate corticophobia (TOPICOP ≤ 50%), and 49 had severe corticophobia (TOPICOP > 50%). At the χ2 test, corticophobia was associated with mild/moderate AD (OR 20.9487; 95% CI 7.2489–60.5402; p < 0.001), older age of patients (OR 4.1176; 95% CI 1.7880 to 9.4828; p < 0.001), early disease onset (OR 9.8925; 95% CI 2.7064–36.1596; p < 0.001), and previous healthcare professional consultations (OR 4.9279; 95% CI 1.9335–12.5597; p < 0.001). Also, severe parental corticophobia was very significantly associated with severe parental involvement of life quality (OR 33.3333; 95% CI 10.9046–101.8937; p < 0.001) and with high education of parents (gymnasium or university degree) (29/49) (OR 5.2727; 95% CI 2.1927–12.6790; p < 0.001). At logistic regression, high parental DLQI (p < 0.0001), high parental education (p < 0.0338), older age of patients (p = 0.0015), and early disease onset (p < 0.0513) accounted for major risk factors influencing severe parental corticophobia. Assessing risk factors for corticophobia is essential for addressing groups of parents at higher risk for corticophobia using educational programs, to overcome unfounded fears and augment treatment adherence.]]></description><subject>Allergy in children</subject><subject>Atopic dermatitis</subject><subject>Atrophy</subject><subject>Clinical medicine</subject><subject>Corticosteroids</subject><subject>Dermatitis</subject><subject>Dermatology</subject><subject>Drug therapy</subject><subject>Eczema</subject><subject>False information</subject><subject>Fear &amp; phobias</subject><subject>Parents</subject><subject>Parents &amp; parenting</subject><subject>Pediatrics</subject><subject>Phobias</subject><subject>Psychological aspects</subject><subject>Questionnaires</subject><subject>Risk factors</subject><subject>Steroids</subject><subject>Surveys</subject><subject>Topical medication</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNptkU1rGzEQhpfSQkOSU_-AIJdAcaIPb0abm9k2TSDBJknPy6xWsuXsrlyNTMklv70yCeSDag6aGZ73ZZgpim-CnyhV8dO1GYSU4kwL9anYkxxgwpVWn9_kX4tDojXPT-upFLBXPNUhJm_CZhVajwyHMC7ZAqMdE7HgWL3yfZcr9tenFZulsPGG_bBxwOSTp3M2I7JEPqtucB0iw7FjN37M2a2nB3aBJoVIzOXGpV-u2P18cVXPF-zOhGjpoPjisCd7-PLvF78vft7Xl5Pr-a-renY9MarSaeIAnJCdECaPrUTrVGfOuK6qslQdyBYdVrI1ILBUTluBGqAE5BKgcy1KtV8cP_tuYviztZSawZOxfY-jDVtqpM5mVSmgyujRB3QdtnHM0-0oLYDrcvpKLbG3jR9dSBHNzrSZAchSqSmITJ38h8rR2SEvfbTO5_47wfdngYmBKFrXbKIfMD42gje7Kzdvrqz-AURMl9U</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Herzum, Astrid</creator><creator>Occella, Corrado</creator><creator>Gariazzo, Lodovica</creator><creator>Pastorino, Carlotta</creator><creator>Viglizzo, Gianmaria</creator><general>MDPI AG</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6373-8801</orcidid></search><sort><creationdate>20231101</creationdate><title>Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores</title><author>Herzum, Astrid ; Occella, Corrado ; Gariazzo, Lodovica ; Pastorino, Carlotta ; Viglizzo, Gianmaria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-f77f12d11c84231bf3dc60899553d72bafa92bc71a53f8e1a87757a0277dfba23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Allergy in children</topic><topic>Atopic dermatitis</topic><topic>Atrophy</topic><topic>Clinical medicine</topic><topic>Corticosteroids</topic><topic>Dermatitis</topic><topic>Dermatology</topic><topic>Drug therapy</topic><topic>Eczema</topic><topic>False information</topic><topic>Fear &amp; phobias</topic><topic>Parents</topic><topic>Parents &amp; parenting</topic><topic>Pediatrics</topic><topic>Phobias</topic><topic>Psychological aspects</topic><topic>Questionnaires</topic><topic>Risk factors</topic><topic>Steroids</topic><topic>Surveys</topic><topic>Topical medication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Herzum, Astrid</creatorcontrib><creatorcontrib>Occella, Corrado</creatorcontrib><creatorcontrib>Gariazzo, Lodovica</creatorcontrib><creatorcontrib>Pastorino, Carlotta</creatorcontrib><creatorcontrib>Viglizzo, Gianmaria</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Herzum, Astrid</au><au>Occella, Corrado</au><au>Gariazzo, Lodovica</au><au>Pastorino, Carlotta</au><au>Viglizzo, Gianmaria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores</atitle><jtitle>Journal of clinical medicine</jtitle><date>2023-11-01</date><risdate>2023</risdate><volume>12</volume><issue>21</issue><spage>6813</spage><pages>6813-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract><![CDATA[Corticophobia, fear of applying topical corticosteroids (TCSs), is a rising issue in industrialized countries, despite the actual safety of TCSs for atopic dermatitis (AD). Patients attending the Pediatric Dermatology Unit for skin examination were screened for AD. AD patients were included, and data were collected. Parental corticophobia was evaluated through the Topical Corticosteroid Phobia (TOPICOP) questionnaire. The χ2 test and logistic regression were used to analyze statistical associations between parental corticophobia (mild/moderate vs. severe) and patients’ and parents’ characteristics. Overall, 100 patients were included (53 females; 47 males; mean age 5.9 years): 44 had mild/moderate AD (EASI ≤ 21), and 56 had severe AD (EASI > 21) (mean EASI 19.7). Of the patients, 33 never consulted healthcare providers for AD, and 67 did. Parental education was low/intermediate in 60 cases and high (gymnasium/university degree) in 40. Mean parental DLQI was 10.7. Mean parental TOPICOP was 39.1%: 51 had mild/moderate corticophobia (TOPICOP ≤ 50%), and 49 had severe corticophobia (TOPICOP > 50%). At the χ2 test, corticophobia was associated with mild/moderate AD (OR 20.9487; 95% CI 7.2489–60.5402; p < 0.001), older age of patients (OR 4.1176; 95% CI 1.7880 to 9.4828; p < 0.001), early disease onset (OR 9.8925; 95% CI 2.7064–36.1596; p < 0.001), and previous healthcare professional consultations (OR 4.9279; 95% CI 1.9335–12.5597; p < 0.001). Also, severe parental corticophobia was very significantly associated with severe parental involvement of life quality (OR 33.3333; 95% CI 10.9046–101.8937; p < 0.001) and with high education of parents (gymnasium or university degree) (29/49) (OR 5.2727; 95% CI 2.1927–12.6790; p < 0.001). At logistic regression, high parental DLQI (p < 0.0001), high parental education (p < 0.0338), older age of patients (p = 0.0015), and early disease onset (p < 0.0513) accounted for major risk factors influencing severe parental corticophobia. Assessing risk factors for corticophobia is essential for addressing groups of parents at higher risk for corticophobia using educational programs, to overcome unfounded fears and augment treatment adherence.]]></abstract><cop>Basel</cop><pub>MDPI AG</pub><doi>10.3390/jcm12216813</doi><orcidid>https://orcid.org/0000-0001-6373-8801</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2023-11, Vol.12 (21), p.6813
issn 2077-0383
2077-0383
language eng
recordid cdi_proquest_miscellaneous_2889995179
source MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access
subjects Allergy in children
Atopic dermatitis
Atrophy
Clinical medicine
Corticosteroids
Dermatitis
Dermatology
Drug therapy
Eczema
False information
Fear & phobias
Parents
Parents & parenting
Pediatrics
Phobias
Psychological aspects
Questionnaires
Risk factors
Steroids
Surveys
Topical medication
title Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T14%3A29%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corticophobia%20among%20Parents%20of%20Children%20with%20Atopic%20Dermatitis:%20Assessing%20Major%20and%20Minor%20Risk%20Factors%20for%20High%20TOPICOP%20Scores&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Herzum,%20Astrid&rft.date=2023-11-01&rft.volume=12&rft.issue=21&rft.spage=6813&rft.pages=6813-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm12216813&rft_dat=%3Cgale_proqu%3EA772533471%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2888170854&rft_id=info:pmid/&rft_galeid=A772533471&rfr_iscdi=true